Upstream Bio, Inc. (UPB)
29.86
+1.53
(+5.40%)
USD |
NASDAQ |
Dec 18, 16:00
29.78
-0.08
(-0.27%)
After-Hours: 20:00
Upstream Bio Market Cap: 1.610B for Dec. 18, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 16.69M |
| AIM ImmunoTech, Inc. | 1.040M |
| IGC Pharma, Inc. | 31.21M |
| NovaBay Pharmaceuticals, Inc. | 371.73M |
| Protalix Biotherapeutics, Inc. | 144.76M |
Market Cap Related Metrics
| PS Ratio | 573.27 |
| Price to Book Value | 4.252 |
| Price | 29.86 |
| Earnings Yield | -7.65% |